🇺🇸 Bupivacaine Hydrochloride And Epinephrine in United States

FDA authorised Bupivacaine Hydrochloride And Epinephrine on 3 October 1972

Marketing authorisations

FDA — authorised 3 October 1972

  • Application: NDA016964
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: MARCAINE HYDROCHLORIDE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

Bupivacaine Hydrochloride And Epinephrine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bupivacaine Hydrochloride And Epinephrine approved in United States?

Yes. FDA authorised it on 3 October 1972; FDA has authorised it.

Who is the marketing authorisation holder for Bupivacaine Hydrochloride And Epinephrine in United States?

HOSPIRA holds the US marketing authorisation.